Cipher Pharmaceuticals, Inc. (CPH.TO)
14.67
-0.19
(-1.28%)
CAD |
TSX |
Sep 18, 16:00
Cipher Pharmaceuticals Price to Book Value : 1.915 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.915 |
| September 17, 2026 | 1.939 |
| September 16, 2026 | 1.894 |
| September 15, 2026 | 1.900 |
| September 14, 2026 | 1.928 |
| September 11, 2026 | 1.866 |
| September 10, 2026 | 1.853 |
| September 09, 2026 | 1.858 |
| September 08, 2026 | 1.847 |
| September 04, 2026 | 1.872 |
| September 03, 2026 | 1.878 |
| September 02, 2026 | 1.898 |
| September 01, 2026 | 1.852 |
| August 31, 2026 | 1.785 |
| August 28, 2026 | 1.821 |
| August 27, 2026 | 1.848 |
| August 26, 2026 | 1.840 |
| August 25, 2026 | 1.848 |
| August 24, 2026 | 1.840 |
| August 21, 2026 | 1.840 |
| August 20, 2026 | 1.869 |
| August 19, 2026 | 1.874 |
| August 18, 2026 | 1.868 |
| August 17, 2026 | 1.868 |
| August 14, 2026 | 1.846 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.826 |
| August 12, 2026 | 1.842 |
| August 11, 2026 | 2.343 |
| August 10, 2026 | 2.293 |
| August 07, 2026 | 2.290 |
| August 06, 2026 | 2.317 |
| August 05, 2026 | 2.208 |
| August 04, 2026 | 2.228 |
| July 31, 2026 | 2.197 |
| July 30, 2026 | 2.148 |
| July 29, 2026 | 2.135 |
| July 28, 2026 | 2.129 |
| July 27, 2026 | 2.144 |
| July 24, 2026 | 2.121 |
| July 23, 2026 | 2.146 |
| July 21, 2026 | 2.163 |
| July 20, 2026 | 2.143 |
| July 17, 2026 | 2.140 |
| July 16, 2026 | 2.139 |
| July 15, 2026 | 2.172 |
| July 14, 2026 | 2.187 |
| July 13, 2026 | 2.206 |
| July 10, 2026 | 2.236 |
| July 09, 2026 | 2.210 |
| July 08, 2026 | 2.220 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| HLS Therapeutics, Inc. | 1.560 |
| Bausch Health Cos., Inc. | -- |
| BioSyent, Inc. | 3.891 |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | 1.261 |
Price to Book Value Related Metrics
| PE Ratio | 9.458 |
| PS Ratio | 5.523 |
| PEG Ratio | 0.0682 |
| Price to Free Cash Flow | 10.48 |
| Price | 14.67 |
| Earnings Yield | 10.57% |
| Market Cap | 372.84M |
| PEGY Ratio | 0.0682 |
| Operating PE Ratio | 14.25 |
| Normalized PE Ratio | 9.458 |